These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26491908)

  • 1. T1-weighted Dynamic Contrast-enhanced MR Imaging of the Lung in Asthma: Semiquantitative Analysis for the Assessment of Contrast Agent Kinetic Characteristics.
    Zhang WJ; Niven RM; Young SS; Liu YZ; Parker GJ; Naish JH
    Radiology; 2016 Mar; 278(3):906-16. PubMed ID: 26491908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic oxygen-enhanced magnetic resonance imaging of the lung in asthma -- initial experience.
    Zhang WJ; Niven RM; Young SS; Liu YZ; Parker GJ; Naish JH
    Eur J Radiol; 2015 Feb; 84(2):318-26. PubMed ID: 25467640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast Agents.
    Ramalho J; Castillo M; AlObaidy M; Nunes RH; Ramalho M; Dale BM; Semelka RC
    Radiology; 2015 Sep; 276(3):836-44. PubMed ID: 26079490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of Dynamic Contrast-enhanced and Diffusion-weighted MR Imaging in the Detection of Pathologic Complete Response in Cervical Cancer after Neoadjuvant Therapy: A Retrospective Observational Study.
    Jalaguier-Coudray A; Villard-Mahjoub R; Delouche A; Delarbre B; Lambaudie E; Houvenaeghel G; Minsat M; Tallet A; Sabatier R; Thomassin-Naggara I
    Radiology; 2017 Aug; 284(2):432-442. PubMed ID: 28301309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumoral and nontumoral pancreas: correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters.
    Bali MA; Metens T; Denolin V; Delhaye M; Demetter P; Closset J; Matos C
    Radiology; 2011 Nov; 261(2):456-66. PubMed ID: 21852570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
    Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
    Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast-enhanced MRI: Study of inter-software accuracy and reproducibility using simulated and clinical data.
    Beuzit L; Eliat PA; Brun V; Ferré JC; Gandon Y; Bannier E; Saint-Jalmes H
    J Magn Reson Imaging; 2016 Jun; 43(6):1288-300. PubMed ID: 26687041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal breast parenchyma: contrast enhancement kinetics at dynamic MR mammography--influence of anthropometric measures and menopausal status.
    Hegenscheid K; Schmidt CO; Seipel R; Laqua R; Ohlinger R; Kühn JP; Hosten N; Puls R
    Radiology; 2013 Jan; 266(1):72-80. PubMed ID: 23023963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving malignancy prediction in breast lesions with the combination of apparent diffusion coefficient and dynamic contrast-enhanced kinetic descriptors.
    Nogueira L; Brandão S; Matos E; Gouveia Nunes R; Ferreira HA; Loureiro J; Ramos I
    Clin Radiol; 2015 Sep; 70(9):1016-25. PubMed ID: 26135541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-small cell lung cancer: detection of early response to chemotherapy by using contrast-enhanced dynamic and diffusion-weighted MR imaging.
    Yabuuchi H; Hatakenaka M; Takayama K; Matsuo Y; Sunami S; Kamitani T; Jinnouchi M; Sakai S; Nakanishi Y; Honda H
    Radiology; 2011 Nov; 261(2):598-604. PubMed ID: 21852569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celiac disease: evaluation with dynamic contrast-enhanced MR imaging.
    Masselli G; Picarelli A; Di Tola M; Libanori V; Donato G; Polettini E; Piermattei A; Palumbo P; Pittalis A; Saponara A; Gualdi G
    Radiology; 2010 Sep; 256(3):783-90. PubMed ID: 20663971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility.
    Kim HS; Goh MJ; Kim N; Choi CG; Kim SJ; Kim JH
    Radiology; 2014 Dec; 273(3):831-43. PubMed ID: 24885857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent.
    Radbruch A; Weberling LD; Kieslich PJ; Eidel O; Burth S; Kickingereder P; Heiland S; Wick W; Schlemmer HP; Bendszus M
    Radiology; 2015 Jun; 275(3):783-91. PubMed ID: 25848905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging--perfusion differences in malignant and benign lesions.
    Schaefer JF; Vollmar J; Schick F; Vonthein R; Seemann MD; Aebert H; Dierkesmann R; Friedel G; Claussen CD
    Radiology; 2004 Aug; 232(2):544-53. PubMed ID: 15215548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.
    Pinker K; Bogner W; Baltzer P; Gruber S; Bickel H; Brueck B; Trattnig S; Weber M; Dubsky P; Bago-Horvath Z; Bartsch R; Helbich TH
    Invest Radiol; 2014 Jun; 49(6):421-30. PubMed ID: 24566292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Gadolinium-BOPTA and Ferucarbotran-enhanced three-dimensional T1-weighted dynamic liver magnetic resonance imaging in the same patient.
    Wersebe A; Wiskirchen J; Decker U; Schick F; Dietz K; Müller-Schimpfle M; Claussen CD; Pereira PL
    Invest Radiol; 2006 Mar; 41(3):264-71. PubMed ID: 16481909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast-enhanced case-control analysis in 3T MRI of prostate cancer can help to characterize tumor aggressiveness.
    Sanz-Requena R; Martí-Bonmatí L; Pérez-Martínez R; García-Martí G
    Eur J Radiol; 2016 Nov; 85(11):2119-2126. PubMed ID: 27776667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Dynamic Contrast-Enhancement Parameters between Gadobutrol and Gadoterate Meglumine in Posttreatment Glioma: A Prospective Intraindividual Study.
    Park JE; Kim JY; Kim HS; Shim WH
    AJNR Am J Neuroradiol; 2020 Nov; 41(11):2041-2048. PubMed ID: 33060100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glandular function in Sjögren syndrome: assessment with dynamic contrast-enhanced MR imaging and tracer kinetic modeling--initial experience.
    Roberts C; Parker GJ; Rose CJ; Watson Y; O'Connor JP; Stivaros SM; Jackson A; Rushton VE
    Radiology; 2008 Mar; 246(3):845-53. PubMed ID: 18235107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.